Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Frequency modulated hybrid photonic crystal laser by thermal tuning.

Butler SM, Bakoz AP, Singaravelu PKJ, Liles AA, O'Shaughnessy B, Viktorov EA, O'Faolain L, Hegarty SP.

Opt Express. 2019 Apr 15;27(8):11312-11322. doi: 10.1364/OE.27.011312.

PMID:
31052977
2.

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Intraocular Pressure Measurements Found in a Population at High Risk for Glaucoma.

Hark LA, Myers JS, Pasquale LR, Razeghinejad MR, Maity A, Zhan T, Hegarty SE, Leiby BE, Waisbourd M, Burns C, Divers M, Molineaux J, Henderer JD, Haller JA, Katz LJ.

J Glaucoma. 2019 Apr;28(4):294-301. doi: 10.1097/IJG.0000000000001207.

PMID:
30946709
3.

Quantitative sensory testing in children with sickle cell disease: additional insights and future possibilities.

Miller RE, Brown DS, Keith SW, Hegarty SE, Setty Y, Campbell CM, McCahan SM, Gayen-Betal S, Byck H, Stuart M.

Br J Haematol. 2019 Mar 28. doi: 10.1111/bjh.15876. [Epub ahead of print]

PMID:
30924134
4.

Experimental electric field visualisation of multi-mode dynamics in a short cavity swept laser designed for OCT applications.

Butler TP, Goulding D, Slepneva S, O'Shaughnessy B, Hegarty SP, Huyet G, Kelleher B.

Opt Express. 2019 Mar 4;27(5):7307-7318. doi: 10.1364/OE.27.007307.

PMID:
30876296
5.

Treatment plan consistency with guidelines for older adults with cancer.

MacKenzie AR, Barsevick AM, Myers R, Hegarty SE, Keith SW, Patel S, Lapinsky E, Schoppe J, Williams U 3rd, Chapman AE.

J Geriatr Oncol. 2019 Mar 6. pii: S1879-4068(18)30296-0. doi: 10.1016/j.jgo.2019.01.022. [Epub ahead of print] No abstract available.

PMID:
30852179
6.

Wavelength stability in a hybrid photonic crystal laser through controlled nonlinear absorptive heating in the reflector.

Bakoz AP, Liles AA, Gonzalez-Fernandez AA, Habruseva T, Hu C, Viktorov EA, Hegarty SP, O'Faolain L.

Light Sci Appl. 2018 Jul 25;7:39. doi: 10.1038/s41377-018-0043-8. eCollection 2018.

7.

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: confirmation between eye screening and comprehensive eye examination diagnoses.

Hark LA, Myers JS, Ines A, Jiang A, Rahmatnejad K, Zhan T, Leiby BE, Hegarty S, Fudemberg SJ, Mantravadi AV, Waisbourd M, Henderer JD, Burns C, Divers M, Molineaux J, Pizzi LT, Murchison AP, Saaddine J, Pasquale LR, Haller JA, Katz LJ.

Br J Ophthalmol. 2019 Feb 15. pii: bjophthalmol-2018-313451. doi: 10.1136/bjophthalmol-2018-313451. [Epub ahead of print]

PMID:
30770354
8.

Mid-infrared optical sensing using sub-wavelength gratings.

Hogan B, Lewis L, McAuliffe M, Hegarty SP.

Opt Express. 2019 Feb 4;27(3):3169-3179. doi: 10.1364/OE.27.003169.

PMID:
30732342
9.

Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.

Giri VN, Hegarty SE, Hyatt C, O'Leary E, Garcia J, Knudsen KE, Kelly WK, Gomella LG.

Prostate. 2019 Mar;79(4):333-339. doi: 10.1002/pros.23739. Epub 2018 Nov 18.

PMID:
30450585
10.

Decision Support and Navigation to Increase Colorectal Cancer Screening Among Hispanic Patients.

Myers RE, Stello B, Daskalakis C, Sifri R, González ET, DiCarlo M, Johnson MB, Hegarty SE, Shaak K, Rivera A, Gordils-Molina L, Petrich A, Careyva B, de-Ortiz R, Diaz L.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):384-391. doi: 10.1158/1055-9965.EPI-18-0260. Epub 2018 Oct 17.

PMID:
30333221
11.

Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.

Chen B, Li Y, Yu B, Zhang Z, Brommer B, Williams PR, Liu Y, Hegarty SV, Zhou S, Zhu J, Guo H, Lu Y, Zhang Y, Gu X, He Z.

Cell. 2018 Sep 6;174(6):1599. doi: 10.1016/j.cell.2018.08.050. No abstract available.

12.

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Analysis of Unreadable Fundus Images.

Hark LA, Myers JS, Rahmatnejad K, Wang Q, Zhan T, Hegarty SE, Leiby BE, Udyaver S, Waisbourd M, Leite S, Henderer JD, Pasquale LR, Lee PP, Haller JA, Katz LJ.

J Glaucoma. 2018 Nov;27(11):999-1008. doi: 10.1097/IJG.0000000000001082.

PMID:
30180021
13.

Thermally stable hybrid cavity laser based on silicon nitride gratings.

Iadanza S, Bakoz AP, Singaravelu PKJ, Panettieri D, Schulz SA, Devarapu GCR, Guerber S, Baudot C, Boeuf F, Hegarty S, O'Faolain L.

Appl Opt. 2018 Aug 1;57(22):E218-E223. doi: 10.1364/AO.57.00E218.

PMID:
30117905
14.

Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.

Chen B, Li Y, Yu B, Zhang Z, Brommer B, Williams PR, Liu Y, Hegarty SV, Zhou S, Zhu J, Guo H, Lu Y, Zhang Y, Gu X, He Z.

Cell. 2018 Jul 26;174(3):521-535.e13. doi: 10.1016/j.cell.2018.06.005. Epub 2018 Jul 19. Erratum in: Cell. 2018 Sep 6;174(6):1599.

PMID:
30033363
15.

Effectiveness of palliative care services: A population-based study of end-of-life care for cancer patients.

De Palma R, Fortuna D, Hegarty SE, Louis DZ, Melotti RM, Moro ML.

Palliat Med. 2018 Sep;32(8):1344-1352. doi: 10.1177/0269216318778729. Epub 2018 Jun 11.

PMID:
29886795
16.

Resonant gratings with an etch-stop layer and a fabrication-error tolerant design.

Hogan B, Lewis L, Romero-Vivas J, Ochalski TJ, Hegarty SP.

Opt Express. 2018 May 14;26(10):13205-13213. doi: 10.1364/OE.26.013205.

PMID:
29801347
17.

How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?

Djatche L, Lee S, Singer D, Hegarty SE, Lombardi M, Maio V.

J Clin Pharm Ther. 2018 Aug;43(4):550-555. doi: 10.1111/jcpt.12688. Epub 2018 Apr 22.

PMID:
29682764
18.

Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.

Giri VN, Obeid E, Hegarty SE, Gross L, Bealin L, Hyatt C, Fang CY, Leader A.

Prostate. 2018 Sep;78(12):879-888. doi: 10.1002/pros.23535. Epub 2018 Apr 14.

PMID:
29655297
19.

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Neural Regen Res. 2017 Nov;12(11):1814-1815. doi: 10.4103/1673-5374.219039. No abstract available.

20.

Direct experimental measurement of single-mode and mode-hopping dynamics in frequency swept lasers.

Butler TP, Goulding D, Kelleher B, O'Shaughnessy B, Slepneva S, Hegarty SP, Huyet G.

Opt Express. 2017 Oct 30;25(22):27464-27474. doi: 10.1364/OE.25.027464.

PMID:
29092219
21.

Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring.

Curran EA, O'Keeffe GW, Looney AM, Moloney G, Hegarty SV, Murray DM, Khashan AS, Kenny LC.

Mol Neurobiol. 2018 Jul;55(7):5557-5564. doi: 10.1007/s12035-017-0794-x. Epub 2017 Oct 3.

PMID:
28975539
22.

Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation.

Hegarty SV, Wyatt SL, Howard L, Stappers E, Huylebroeck D, Sullivan AM, O'Keeffe GW.

Sci Rep. 2017 Aug 17;7(1):8568. doi: 10.1038/s41598-017-08900-3.

23.

Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults.

Varga S, Alcusky M, Keith SW, Hegarty SE, Del Canale S, Lombardi M, Maio V.

Br J Clin Pharmacol. 2017 Nov;83(11):2572-2580. doi: 10.1111/bcp.13365. Epub 2017 Aug 4.

24.

Romidepsin induces caspase-dependent cell death in human neuroblastoma cells.

Hegarty SV, Togher KL, O'Leary E, Solger F, Sullivan AM, O'Keeffe GW.

Neurosci Lett. 2017 Jul 13;653:12-18. doi: 10.1016/j.neulet.2017.05.025. Epub 2017 May 12.

PMID:
28506690
25.

Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo.

Vicente-Perez EM, Larrañeta E, McCrudden MTC, Kissenpfennig A, Hegarty S, McCarthy HO, Donnelly RF.

Eur J Pharm Biopharm. 2017 Aug;117:400-407. doi: 10.1016/j.ejpb.2017.04.029. Epub 2017 May 3.

26.

Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis.

Hegarty SV, Lee DJ, O'Keeffe GW, Sullivan AM.

Parkinsonism Relat Disord. 2017 May;38:19-25. doi: 10.1016/j.parkreldis.2017.02.011. Epub 2017 Feb 10. Review.

PMID:
28215730
27.

Endocytosis contributes to BMP2-induced Smad signalling and neuronal growth.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Neurosci Lett. 2017 Mar 16;643:32-37. doi: 10.1016/j.neulet.2017.02.013. Epub 2017 Feb 8.

PMID:
28188849
28.

The Epigenome as a therapeutic target for Parkinson's disease.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Neural Regen Res. 2016 Nov;11(11):1735-1738. doi: 10.4103/1673-5374.194803. Review.

29.

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.

Truong H, Hegarty SE, Gomella LG, Kelly WK, Trabulsi EJ, Lallas CD, Giri VN.

J Genet Couns. 2017 Jun;26(3):548-555. doi: 10.1007/s10897-016-0020-4. Epub 2017 Jan 19.

PMID:
28101821
30.

A Comparative Study of the Water Drinking Test in Eyes With Open-Angle Glaucoma and Prior Trabeculectomy or Tube Shunt.

Martinez P, Trubnik V, Leiby BE, Hegarty SE, Razeghinejad R, Savant S, Myers JS.

J Glaucoma. 2017 Feb;26(2):119-125. doi: 10.1097/IJG.0000000000000589.

PMID:
27875485
31.

Realization of high-contrast gratings operating at 10  μm.

Hogan B, Hegarty SP, Lewis L, Romero-Vivas J, Ochalski TJ, Huyet G.

Opt Lett. 2016 Nov 1;41(21):5130-5133. doi: 10.1364/OL.41.005130.

PMID:
27805701
32.

Variation in hospital utilization at the end of life for patients with cancer in the Emilia-Romagna region of Italy.

Louis DZ, Hegarty SE, Leoni M, De Palma R, Varga S, Melotti R.

Tumori. 2016 Dec 1;102(6):614-620. doi: 10.5301/tj.5000544. Epub 2016 Aug 5.

PMID:
27514312
33.

Post-treatment problems of African American breast cancer survivors.

Barsevick AM, Leader A, Bradley PK, Avery T, Dean LT, DiCarlo M, Hegarty SE.

Support Care Cancer. 2016 Dec;24(12):4979-4986. Epub 2016 Aug 19.

34.
35.

Injection-induced, tunable all-optical gating in a two-state quantum dot laser.

Viktorov EA, Dubinkin I, Fedorov N, Erneux T, Tykalewicz B, Hegarty SP, Huyet G, Goulding D, Kelleher B.

Opt Lett. 2016 Aug 1;41(15):3555-8. doi: 10.1364/OL.41.003555.

PMID:
27472617
36.

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.

Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG.

J Cancer Educ. 2018 Feb;33(1):180-185. doi: 10.1007/s13187-016-1073-7.

PMID:
27418065
37.

A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.

Hegarty SV, O'Leary E, Solger F, Stanicka J, Sullivan AM, O'Keeffe GW.

Neurotox Res. 2016 Oct;30(3):510-20. doi: 10.1007/s12640-016-9636-2. Epub 2016 Jun 2.

PMID:
27256286
38.

Optically induced hysteresis in a two-state quantum dot laser.

Tykalewicz B, Goulding D, Hegarty SP, Huyet G, Dubinkin I, Fedorov N, Erneux T, Viktorov EA, Kelleher B.

Opt Lett. 2016 Mar 1;41(5):1034-7. doi: 10.1364/OL.41.001034.

PMID:
26974109
39.

Emergence of resonant mode-locking via delayed feedback in quantum dot semiconductor lasers.

Tykalewicz B, Goulding D, Hegarty SP, Huyet G, Erneux T, Kelleher B, Viktorov EA.

Opt Express. 2016 Feb 22;24(4):4239-46.

PMID:
26907071
40.

Attitudes towards physician-nurse collaboration in a primary care team-based setting: Survey-based research conducted in the chronic care units of the Tuscany region of Italy.

Vegesna A, Coschignano C, Hegarty SE, Karagiannis T, Polenzani L, Messina E, Zoli R, Maio V.

J Interprof Care. 2016;30(1):65-70. doi: 10.3109/13561820.2015.1081878.

PMID:
26833107
41.

Optical ultrafast random number generation at 1 Tb/s using a turbulent semiconductor ring cavity laser.

Butler T, Durkan C, Goulding D, Slepneva S, Kelleher B, Hegarty SP, Huyet G.

Opt Lett. 2016 Jan 15;41(2):388-91. doi: 10.1364/OL.41.000388.

PMID:
26766721
42.

Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.

Trifiletti DM, Swisher-McClure S, Showalter TN, Hegarty SE, Grover S.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1032-44. doi: 10.1016/j.ijrobp.2015.09.001. Epub 2015 Sep 11.

PMID:
26581141
43.

Relationships Between Measures of the Ability to Perform Vision-Related Activities, Vision-Related Quality of Life, and Clinical Findings in Patients With Glaucoma.

Ekici F, Loh R, Waisbourd M, Sun Y, Martinez P, Nayak N, Wizov SS, Hegarty S, Hark LA, Spaeth GL.

JAMA Ophthalmol. 2015 Dec;133(12):1377-85. doi: 10.1001/jamaophthalmol.2015.3426.

PMID:
26425961
44.

Single shot, time-resolved measurement of the coherence properties of OCT swept source lasers.

Butler T, Slepneva S, O'Shaughnessy B, Kelleher B, Goulding D, Hegarty SP, Lyu HC, Karnowski K, Wojtkowski M, Huyet G.

Opt Lett. 2015 May 15;40(10):2277-80. doi: 10.1364/OL.40.002277.

PMID:
26393718
45.

Zeb2: A multifunctional regulator of nervous system development.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Prog Neurobiol. 2015 Sep;132:81-95. doi: 10.1016/j.pneurobio.2015.07.001. Epub 2015 Jul 18. Review.

PMID:
26193487
46.

Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma.

Patel N, Hegarty SE, Cantrell LA, Mishra MV, Showalter TN.

Brachytherapy. 2015 Sep-Oct;14(5):606-12. doi: 10.1016/j.brachy.2015.06.003. Epub 2015 Jul 10.

PMID:
26166579
47.

Definitive Radiation Therapy for Stage I-II Endometrial Cancer: An Observational Study of Nonoperative Management.

Yoo S, Hegarty SE, Mishra MV, Patel N, Cantrell LA, Showalter TN.

Am J Clin Oncol. 2017 Dec;40(6):582-589. doi: 10.1097/COC.0000000000000204.

PMID:
26083557
48.

FKBPL: a marker of good prognosis in breast cancer.

Nelson L, McKeen HD, Marshall A, Mulrane L, Starczynski J, Storr SJ, Lanigan F, Byrne C, Arthur K, Hegarty S, Ali AA, Furlong F, McCarthy HO, Ellis IO, Green AR, Rakha E, Young L, Kunkler I, Thomas J, Jack W, Cameron D, Jirström K, Yakkundi A, McClements L, Martin SG, Gallagher WM, Dunn J, Bartlett J, O'Connor D, Robson T.

Oncotarget. 2015 May 20;6(14):12209-23.

49.

Racial disparity in in-hospital mortality after lobectomy for lung cancer.

Harrison MA, Hegarty SE, Keith SW, Cowan SW, Evans NR 3rd.

Am J Surg. 2015 Apr;209(4):652-8. doi: 10.1016/j.amjsurg.2014.11.006. Epub 2015 Feb 4.

PMID:
25812844
50.

A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lung.

Glasgow AM, Small DM, Scott A, McLean DT, Camper N, Hamid U, Hegarty S, Parekh D, O'Kane C, Lundy FT, McNally P, Elborn JS, McAuley DF, Weldon S, Taggart CC.

Thorax. 2015 May;70(5):426-32. doi: 10.1136/thoraxjnl-2014-206488. Epub 2015 Mar 13.

PMID:
25770093

Supplemental Content

Loading ...
Support Center